Under control of the Ren-1(c) promoter, locally produced transforming growth factor-β1 induces accumulation of glomerular extracellular matrix in transgenic mice

Lise Wogensen, Camilla Birch Nielsen, Peter Hjorth, Lars Melholt Rasmussen, Arne Høj Nielsen, Kenneth Gross, Nora Sarvetnick, Thomas Ledet

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Our purpose was to elucidate the hypothesis that paracrine-produced transforming growth factor (TGF)β1 regulates the accumulation of extracellular matrix (ECM) in renal glomeruli, a hallmark of diabetic nephropathy. To produce TGF-β1 from the juxtaglomerular apparatus in mouse kidneys, we cloned a mouse Ren-1(c) promoter fragment (-4.100 to +6 base pairs) upstream of porcine TGF-β1 (pTGF-β1) cDNA, mutated to ensure secretion of biologically active TGF-β1. The resulting transgenic mice had significantly more TGF-β1 in their kidneys than was in those of nontransgenic controls, as confirmed by immunohistochemistry, and the production of TGF-β1 was enhanced in vivo by captopril-induced stimulation of the Ren-1(c) promoter. Overproduction of pTGF-β1 close to the glomerulus resulted in a local accumulation of ECM, composed partly of collagen type IV and laminin, and thickening of the basement membrane, characteristic features of diabetic nephropathy. Interstitial accumulation of ECM and signs of tubular atrophy were present only in older mice (>5 months of age). Results from in situ hybridization and immunohistochemistry suggest that pTGF-β1 stimulated the production of endogenous TGF-β1 along collecting ducts and connecting tubules. The increased amount of biologically active TGF-β1, transgenic as well as endogenous, was corroborated by heightened proteoglycan synthesis from incubated kidney slices. This transgenic model demonstrates that sustained local expression of TGF-β1 leads to glomerulopathy. We conclude that autocrine- or paracrine-produced TGF-β1 may play a role in the development of glomerular diseases, such as diabetic nephropathy.

Original languageEnglish (US)
Pages (from-to)182-192
Number of pages11
JournalDiabetes
Volume48
Issue number1
DOIs
StatePublished - Jan 1 1999

Fingerprint

Transforming Growth Factors
Transgenic Mice
Extracellular Matrix
Diabetic Nephropathies
Kidney
Swine
Immunohistochemistry
Juxtaglomerular Apparatus
Collagen Type IV
Captopril
Laminin
Proteoglycans
Basement Membrane
Base Pairing
Atrophy
In Situ Hybridization
Complementary DNA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Under control of the Ren-1(c) promoter, locally produced transforming growth factor-β1 induces accumulation of glomerular extracellular matrix in transgenic mice. / Wogensen, Lise; Nielsen, Camilla Birch; Hjorth, Peter; Rasmussen, Lars Melholt; Nielsen, Arne Høj; Gross, Kenneth; Sarvetnick, Nora; Ledet, Thomas.

In: Diabetes, Vol. 48, No. 1, 01.01.1999, p. 182-192.

Research output: Contribution to journalArticle

Wogensen, Lise ; Nielsen, Camilla Birch ; Hjorth, Peter ; Rasmussen, Lars Melholt ; Nielsen, Arne Høj ; Gross, Kenneth ; Sarvetnick, Nora ; Ledet, Thomas. / Under control of the Ren-1(c) promoter, locally produced transforming growth factor-β1 induces accumulation of glomerular extracellular matrix in transgenic mice. In: Diabetes. 1999 ; Vol. 48, No. 1. pp. 182-192.
@article{79a71c7b6a1d4bc0bd1712c7c97587dc,
title = "Under control of the Ren-1(c) promoter, locally produced transforming growth factor-β1 induces accumulation of glomerular extracellular matrix in transgenic mice",
abstract = "Our purpose was to elucidate the hypothesis that paracrine-produced transforming growth factor (TGF)β1 regulates the accumulation of extracellular matrix (ECM) in renal glomeruli, a hallmark of diabetic nephropathy. To produce TGF-β1 from the juxtaglomerular apparatus in mouse kidneys, we cloned a mouse Ren-1(c) promoter fragment (-4.100 to +6 base pairs) upstream of porcine TGF-β1 (pTGF-β1) cDNA, mutated to ensure secretion of biologically active TGF-β1. The resulting transgenic mice had significantly more TGF-β1 in their kidneys than was in those of nontransgenic controls, as confirmed by immunohistochemistry, and the production of TGF-β1 was enhanced in vivo by captopril-induced stimulation of the Ren-1(c) promoter. Overproduction of pTGF-β1 close to the glomerulus resulted in a local accumulation of ECM, composed partly of collagen type IV and laminin, and thickening of the basement membrane, characteristic features of diabetic nephropathy. Interstitial accumulation of ECM and signs of tubular atrophy were present only in older mice (>5 months of age). Results from in situ hybridization and immunohistochemistry suggest that pTGF-β1 stimulated the production of endogenous TGF-β1 along collecting ducts and connecting tubules. The increased amount of biologically active TGF-β1, transgenic as well as endogenous, was corroborated by heightened proteoglycan synthesis from incubated kidney slices. This transgenic model demonstrates that sustained local expression of TGF-β1 leads to glomerulopathy. We conclude that autocrine- or paracrine-produced TGF-β1 may play a role in the development of glomerular diseases, such as diabetic nephropathy.",
author = "Lise Wogensen and Nielsen, {Camilla Birch} and Peter Hjorth and Rasmussen, {Lars Melholt} and Nielsen, {Arne H{\o}j} and Kenneth Gross and Nora Sarvetnick and Thomas Ledet",
year = "1999",
month = "1",
day = "1",
doi = "10.2337/diabetes.48.1.182",
language = "English (US)",
volume = "48",
pages = "182--192",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Under control of the Ren-1(c) promoter, locally produced transforming growth factor-β1 induces accumulation of glomerular extracellular matrix in transgenic mice

AU - Wogensen, Lise

AU - Nielsen, Camilla Birch

AU - Hjorth, Peter

AU - Rasmussen, Lars Melholt

AU - Nielsen, Arne Høj

AU - Gross, Kenneth

AU - Sarvetnick, Nora

AU - Ledet, Thomas

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Our purpose was to elucidate the hypothesis that paracrine-produced transforming growth factor (TGF)β1 regulates the accumulation of extracellular matrix (ECM) in renal glomeruli, a hallmark of diabetic nephropathy. To produce TGF-β1 from the juxtaglomerular apparatus in mouse kidneys, we cloned a mouse Ren-1(c) promoter fragment (-4.100 to +6 base pairs) upstream of porcine TGF-β1 (pTGF-β1) cDNA, mutated to ensure secretion of biologically active TGF-β1. The resulting transgenic mice had significantly more TGF-β1 in their kidneys than was in those of nontransgenic controls, as confirmed by immunohistochemistry, and the production of TGF-β1 was enhanced in vivo by captopril-induced stimulation of the Ren-1(c) promoter. Overproduction of pTGF-β1 close to the glomerulus resulted in a local accumulation of ECM, composed partly of collagen type IV and laminin, and thickening of the basement membrane, characteristic features of diabetic nephropathy. Interstitial accumulation of ECM and signs of tubular atrophy were present only in older mice (>5 months of age). Results from in situ hybridization and immunohistochemistry suggest that pTGF-β1 stimulated the production of endogenous TGF-β1 along collecting ducts and connecting tubules. The increased amount of biologically active TGF-β1, transgenic as well as endogenous, was corroborated by heightened proteoglycan synthesis from incubated kidney slices. This transgenic model demonstrates that sustained local expression of TGF-β1 leads to glomerulopathy. We conclude that autocrine- or paracrine-produced TGF-β1 may play a role in the development of glomerular diseases, such as diabetic nephropathy.

AB - Our purpose was to elucidate the hypothesis that paracrine-produced transforming growth factor (TGF)β1 regulates the accumulation of extracellular matrix (ECM) in renal glomeruli, a hallmark of diabetic nephropathy. To produce TGF-β1 from the juxtaglomerular apparatus in mouse kidneys, we cloned a mouse Ren-1(c) promoter fragment (-4.100 to +6 base pairs) upstream of porcine TGF-β1 (pTGF-β1) cDNA, mutated to ensure secretion of biologically active TGF-β1. The resulting transgenic mice had significantly more TGF-β1 in their kidneys than was in those of nontransgenic controls, as confirmed by immunohistochemistry, and the production of TGF-β1 was enhanced in vivo by captopril-induced stimulation of the Ren-1(c) promoter. Overproduction of pTGF-β1 close to the glomerulus resulted in a local accumulation of ECM, composed partly of collagen type IV and laminin, and thickening of the basement membrane, characteristic features of diabetic nephropathy. Interstitial accumulation of ECM and signs of tubular atrophy were present only in older mice (>5 months of age). Results from in situ hybridization and immunohistochemistry suggest that pTGF-β1 stimulated the production of endogenous TGF-β1 along collecting ducts and connecting tubules. The increased amount of biologically active TGF-β1, transgenic as well as endogenous, was corroborated by heightened proteoglycan synthesis from incubated kidney slices. This transgenic model demonstrates that sustained local expression of TGF-β1 leads to glomerulopathy. We conclude that autocrine- or paracrine-produced TGF-β1 may play a role in the development of glomerular diseases, such as diabetic nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=0032589897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032589897&partnerID=8YFLogxK

U2 - 10.2337/diabetes.48.1.182

DO - 10.2337/diabetes.48.1.182

M3 - Article

C2 - 9892241

AN - SCOPUS:0032589897

VL - 48

SP - 182

EP - 192

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 1

ER -